GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)

 SMAD4_PIG               Reviewed;         552 AA.
Q9GKQ9;
04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
01-MAR-2001, sequence version 1.
07-OCT-2020, entry version 151.
RecName: Full=Mothers against decapentaplegic homolog 4;
Short=MAD homolog 4;
Short=Mothers against DPP homolog 4;
AltName: Full=SMAD family member 4;
Short=SMAD 4;
Short=Smad4;
Name=SMAD4; Synonyms=MADH4;
Sus scrofa (Pig).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
NCBI_TaxID=9823;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Muscle;
Ito Y., Awata T.;
Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
-!- FUNCTION: Common SMAD (co-SMAD) is the coactivator and mediator of
signal transduction by TGF-beta (transforming growth factor). Component
of the heterotrimeric SMAD2/SMAD3-SMAD4 complex that forms in the
nucleus and is required for the TGF-mediated signaling. Promotes
binding of the SMAD2/SMAD4/FAST-1 complex to DNA and provides an
activation function required for SMAD1 or SMAD2 to stimulate
transcription. Component of the multimeric SMAD3/SMAD4/JUN/FOS complex
which forms at the AP1 promoter site; required for synergistic
transcriptional activity in response to TGF-beta. Acts synergistically
with SMAD1 and YY1 in bone morphogenetic protein (BMP)-mediated
cardiac-specific gene expression. Binds to SMAD binding elements (SBEs)
(5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac
activating regions. May act as a tumor suppressor. Positively regulates
PDPK1 kinase activity by stimulating its dissociation from the 14-3-3
protein YWHAQ which acts as a negative regulator (By similarity). In
muscle physiology, plays a central role in the balance between atrophy
and hypertrophy. When recruited by MSTN, promotes atrophy response via
phosphorylated SMAD2/4. MSTN decrease causes SMAD4 release and
subsequent recruitment by the BMP pathway to promote hypertrophy via
phosphorylated SMAD1/5/8 (By similarity). {ECO:0000250}.
-!- SUBUNIT: Monomer. Heterotrimer; with a C-terminally phosphorylated R-
SMAD molecule and to form the transcriptionally active SMAD2/3-SMAD4
complex. Found in a ternary complex composed of SMAD4, STK11/LKB1 and
STK11IP. Interacts with ATF2, COPS5, DACH1, MSG1, SKI, STK11/LKB1,
STK11IP and TRIM33. Found in a complex with SMAD1 and YY1. Associates
with ZNF423 or ZNF521 in response to BMP2 leading to activate
transcription of BMP target genes. Interacts with USP9X. Interacts with
RBPMS. Interacts with WWTR1 (via coiled-coil domain). Interacts with
CITED1 and CITED2. Interacts with PDPK1 (via PH domain). Interacts with
VPS39; this interaction affects heterodimer formation with SMAD3, but
not with SMAD2, and leads to inhibition of SMAD3-dependent
transcription activation. Interactions with VPS39 and SMAD2 may be
mutually exclusive. Interacts with ZC3H3. Interacts (via MH2 domain)
with ZNF451 (via N-terminal zinc-finger domains) (By similarity).
Identified in a complex that contains at least ZNF451, SMAD2, SMAD3 and
SMAD4. Interacts weakly with ZNF8. Interacts with NUP93 and IPO7;
translocates SMAD4 to the nucleus through the NPC upon BMP7 stimulation
resulting in activation of SMAD4 signaling (By similarity). Interacts
with CREB3L1, the interaction takes place upon TGFB1 induction and
SMAD4 acts as CREB3L1 coactivator to induce the expression of genes
involved in the assembly of collagen extracellular matrix (By
similarity). Interacts with DLX1 (By similarity). Interacts with
ZBTB7A; the interaction is direct and stimulated by TGFB1 (By
similarity). Interacts with CREBBP; the recruitment of this
transcriptional coactivator is negatively regulated by ZBTB7A (By
similarity). Interacts with EP300; the interaction with this
transcriptional coactivator is negatively regulated by ZBTB7A (By
similarity). Interacts with HDAC1 (By similarity). Interacts (via MH2
domain) with ZMIZ1 (via SP-RING-type domain); in the TGF-beta signaling
pathway increases the activity of the SMAD3/SMAD4 transcriptional
complex (By similarity). {ECO:0000250|UniProtKB:O70437,
ECO:0000250|UniProtKB:P97471, ECO:0000250|UniProtKB:Q13485}.
-!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13485}. Nucleus
{ECO:0000250|UniProtKB:Q13485}. Note=In the cytoplasm in the absence of
ligand. Migration to the nucleus when complexed with R-SMAD. PDPK1
prevents its nuclear translocation. {ECO:0000250|UniProtKB:Q13485}.
-!- DOMAIN: The MH1 domain is required for DNA binding. {ECO:0000250}.
-!- DOMAIN: The MH2 domain is required for both homomeric and heteromeric
interactions and for transcriptional regulation. Sufficient for nuclear
import (By similarity). {ECO:0000250}.
-!- PTM: Phosphorylated by PDPK1. {ECO:0000250}.
-!- PTM: Monoubiquitinated on Lys-519 by E3 ubiquitin-protein ligase
TRIM33. Monoubiquitination hampers its ability to form a stable complex
with activated SMAD2/3 resulting in inhibition of TGF-beta/BMP
signaling cascade. Deubiquitination by USP9X restores its competence to
mediate TGF-beta signaling (By similarity). {ECO:0000250}.
-!- SIMILARITY: Belongs to the dwarfin/SMAD family. {ECO:0000305}.
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; AB053483; BAB20909.1; -; mRNA.
RefSeq; NP_999237.1; NM_214072.1.
RefSeq; XP_005654486.1; XM_005654429.2.
RefSeq; XP_013840780.1; XM_013985326.1.
SMR; Q9GKQ9; -.
STRING; 9823.ENSSSCP00000004879; -.
PaxDb; Q9GKQ9; -.
PeptideAtlas; Q9GKQ9; -.
PRIDE; Q9GKQ9; -.
Ensembl; ENSSSCT00000004997; ENSSSCP00000004879; ENSSSCG00000004524.
Ensembl; ENSSSCT00005056447; ENSSSCP00005034747; ENSSSCG00005035405.
Ensembl; ENSSSCT00005056485; ENSSSCP00005034770; ENSSSCG00005035405.
Ensembl; ENSSSCT00005056577; ENSSSCP00005034822; ENSSSCG00005035405.
Ensembl; ENSSSCT00015025353; ENSSSCP00015009898; ENSSSCG00015019009.
Ensembl; ENSSSCT00025051229; ENSSSCP00025021863; ENSSSCG00025037625.
Ensembl; ENSSSCT00030080575; ENSSSCP00030036931; ENSSSCG00030057715.
Ensembl; ENSSSCT00035082257; ENSSSCP00035034107; ENSSSCG00035061214.
Ensembl; ENSSSCT00040069956; ENSSSCP00040029823; ENSSSCG00040050916.
Ensembl; ENSSSCT00040070046; ENSSSCP00040029859; ENSSSCG00040050916.
Ensembl; ENSSSCT00045037724; ENSSSCP00045026219; ENSSSCG00045022054.
Ensembl; ENSSSCT00050088108; ENSSSCP00050037783; ENSSSCG00050064683.
Ensembl; ENSSSCT00055010846; ENSSSCP00055008581; ENSSSCG00055005534.
Ensembl; ENSSSCT00060051837; ENSSSCP00060022059; ENSSSCG00060038335.
Ensembl; ENSSSCT00065065919; ENSSSCP00065028560; ENSSSCG00065048170.
Ensembl; ENSSSCT00070033293; ENSSSCP00070027806; ENSSSCG00070016851.
Ensembl; ENSSSCT00070033301; ENSSSCP00070027813; ENSSSCG00070016851.
GeneID; 397142; -.
KEGG; ssc:397142; -.
CTD; 4089; -.
VGNC; VGNC:93218; SMAD4.
eggNOG; KOG3701; Eukaryota.
GeneTree; ENSGT00940000157435; -.
HOGENOM; CLU_026736_1_1_1; -.
InParanoid; Q9GKQ9; -.
KO; K04501; -.
OrthoDB; 905048at2759; -.
TreeFam; TF314923; -.
Reactome; R-SSC-1181150; Signaling by NODAL.
Reactome; R-SSC-1502540; Signaling by Activin.
Reactome; R-SSC-201451; Signaling by BMP.
Reactome; R-SSC-2173789; TGF-beta receptor signaling activates SMADs.
Reactome; R-SSC-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
Reactome; R-SSC-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
Reactome; R-SSC-5689880; Ub-specific processing proteases.
Reactome; R-SSC-8941326; RUNX2 regulates bone development.
Reactome; R-SSC-9617828; FOXO-mediated transcription of cell cycle genes.
Proteomes; UP000008227; Chromosome 1.
Proteomes; UP000314985; Chromosome 1.
Bgee; ENSSSCG00000004524; Expressed in skeletal muscle tissue and 36 other tissues.
ExpressionAtlas; Q9GKQ9; baseline and differential.
Genevisible; Q9GKQ9; SS.
GO; GO:0032444; C:activin responsive factor complex; IEA:Ensembl.
GO; GO:0005813; C:centrosome; IEA:Ensembl.
GO; GO:0005829; C:cytosol; IEA:Ensembl.
GO; GO:0000790; C:nuclear chromatin; IEA:Ensembl.
GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
GO; GO:0071141; C:SMAD protein complex; IEA:Ensembl.
GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
GO; GO:0005518; F:collagen binding; IEA:Ensembl.
GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
GO; GO:0070411; F:I-SMAD binding; IEA:Ensembl.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
GO; GO:0070412; F:R-SMAD binding; IEA:Ensembl.
GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
GO; GO:0001085; F:RNA polymerase II transcription factor binding; IEA:Ensembl.
GO; GO:0043199; F:sulfate binding; IEA:Ensembl.
GO; GO:0001223; F:transcription coactivator binding; IEA:Ensembl.
GO; GO:0036302; P:atrioventricular canal development; IEA:Ensembl.
GO; GO:0003190; P:atrioventricular valve formation; IEA:Ensembl.
GO; GO:0007411; P:axon guidance; IEA:Ensembl.
GO; GO:0030509; P:BMP signaling pathway; IEA:Ensembl.
GO; GO:0003360; P:brainstem development; IEA:Ensembl.
GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
GO; GO:0008283; P:cell population proliferation; IEA:Ensembl.
GO; GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl.
GO; GO:0048589; P:developmental growth; IEA:Ensembl.
GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
GO; GO:0060956; P:endocardial cell differentiation; IEA:Ensembl.
GO; GO:0007492; P:endoderm development; IEA:Ensembl.
GO; GO:0042118; P:endothelial cell activation; IEA:Ensembl.
GO; GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; IEA:Ensembl.
GO; GO:0061040; P:female gonad morphogenesis; IEA:Ensembl.
GO; GO:0048859; P:formation of anatomical boundary; IEA:Ensembl.
GO; GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl.
GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
GO; GO:0070102; P:interleukin-6-mediated signaling pathway; IEA:Ensembl.
GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
GO; GO:0003220; P:left ventricular cardiac muscle tissue morphogenesis; IEA:Ensembl.
GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
GO; GO:0072133; P:metanephric mesenchyme morphogenesis; IEA:Ensembl.
GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IEA:Ensembl.
GO; GO:1905305; P:negative regulation of cardiac myofibril assembly; IEA:Ensembl.
GO; GO:0060548; P:negative regulation of cell death; IEA:Ensembl.
GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.
GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0072134; P:nephrogenic mesenchyme morphogenesis; IEA:Ensembl.
GO; GO:0014033; P:neural crest cell differentiation; IEA:Ensembl.
GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
GO; GO:0003148; P:outflow tract septum morphogenesis; IEA:Ensembl.
GO; GO:0001541; P:ovarian follicle development; IEA:Ensembl.
GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
GO; GO:0003251; P:positive regulation of cell proliferation involved in heart valve morphogenesis; IEA:Ensembl.
GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IEA:Ensembl.
GO; GO:0046881; P:positive regulation of follicle-stimulating hormone secretion; IEA:Ensembl.
GO; GO:0051571; P:positive regulation of histone H3-K4 methylation; IEA:Ensembl.
GO; GO:2000617; P:positive regulation of histone H3-K9 acetylation; IEA:Ensembl.
GO; GO:0033686; P:positive regulation of luteinizing hormone secretion; IEA:Ensembl.
GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IEA:Ensembl.
GO; GO:1902895; P:positive regulation of pri-miRNA transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0060391; P:positive regulation of SMAD protein signal transduction; IEA:Ensembl.
GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
GO; GO:0051098; P:regulation of binding; IEA:Ensembl.
GO; GO:0051797; P:regulation of hair follicle development; IEA:Ensembl.
GO; GO:0032909; P:regulation of transforming growth factor beta2 production; IEA:Ensembl.
GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
GO; GO:0048733; P:sebaceous gland development; IEA:Ensembl.
GO; GO:0062009; P:secondary palate development; IEA:Ensembl.
GO; GO:0072520; P:seminiferous tubule development; IEA:Ensembl.
GO; GO:0007338; P:single fertilization; IEA:Ensembl.
GO; GO:0007183; P:SMAD protein complex assembly; IEA:Ensembl.
GO; GO:0060395; P:SMAD protein signal transduction; IEA:Ensembl.
GO; GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl.
GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
GO; GO:0060065; P:uterus development; IEA:Ensembl.
GO; GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl.
Gene3D; 2.60.200.10; -; 1.
Gene3D; 3.90.520.10; -; 1.
InterPro; IPR013790; Dwarfin.
InterPro; IPR003619; MAD_homology1_Dwarfin-type.
InterPro; IPR013019; MAD_homology_MH1.
InterPro; IPR017855; SMAD-like_dom_sf.
InterPro; IPR001132; SMAD_dom_Dwarfin-type.
InterPro; IPR008984; SMAD_FHA_dom_sf.
InterPro; IPR036578; SMAD_MH1_sf.
PANTHER; PTHR13703; PTHR13703; 1.
Pfam; PF03165; MH1; 1.
Pfam; PF03166; MH2; 1.
SMART; SM00523; DWA; 1.
SMART; SM00524; DWB; 1.
SUPFAM; SSF49879; SSF49879; 1.
SUPFAM; SSF56366; SSF56366; 1.
PROSITE; PS51075; MH1; 1.
PROSITE; PS51076; MH2; 1.
2: Evidence at transcript level;
Acetylation; Cytoplasm; DNA-binding; Isopeptide bond; Metal-binding;
Nucleus; Reference proteome; Transcription; Transcription regulation;
Ubl conjugation; Zinc.
CHAIN 1..552
/note="Mothers against decapentaplegic homolog 4"
/id="PRO_0000090863"
DOMAIN 18..142
/note="MH1"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00438"
DOMAIN 323..552
/note="MH2"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00439"
REGION 1..322
/note="Mediates interaction with ZBTB7A"
/evidence="ECO:0000250|UniProtKB:Q13485"
REGION 275..320
/note="SAD"
COMPBIAS 451..466
/note="Poly-Ala"
METAL 71
/note="Zinc"
/evidence="ECO:0000250"
METAL 115
/note="Zinc"
/evidence="ECO:0000250"
METAL 127
/note="Zinc"
/evidence="ECO:0000250"
METAL 132
/note="Zinc"
/evidence="ECO:0000250"
SITE 515
/note="Necessary for heterotrimerization"
/evidence="ECO:0000250"
MOD_RES 37
/note="N6-acetyllysine"
/evidence="ECO:0000250|UniProtKB:Q13485"
MOD_RES 428
/note="N6-acetyllysine"
/evidence="ECO:0000250|UniProtKB:Q13485"
MOD_RES 507
/note="N6-acetyllysine"
/evidence="ECO:0000250|UniProtKB:Q13485"
CROSSLNK 113
/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
G-Cter in SUMO2)"
/evidence="ECO:0000250|UniProtKB:Q13485"
CROSSLNK 519
/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
G-Cter in ubiquitin)"
/evidence="ECO:0000250|UniProtKB:Q13485"
SEQUENCE 552 AA; 60415 MW; 4304796DE7571CB3 CRC64;
MDNMSITNTP TSNDACLSIV HSLMCHRQGG ESETFAKRAI ESLVKKLKEK KDELDSLITA
ITTNGAHPSK CVTIQRTLDG RLQVAGRKGF PHVIYARLWR WPDLHKNELK HVKYCQYAFD
LKCDSVCVNP YHYERVVSPG IDLSGLTLQS NAPSGMLVKD EYVHDFEGQP SLATEGHSIQ
TIQHPPSNRA STETYSTPAL LAPSESNATS TTNFPNIPVA STSQPASILA GSHSEGLLQI
ASGPQPGQQQ NGFTGQPATY HHNSTTTWTG SRTAPYPPNL PHHQNGHLQH HPPMPPHPGH
YWPVHNELAF QPPISNHPAP EYWCSIAYFE MDVQVGETFK VPSSCPIVTV DGYVDPSGGD
RFCLGQLSNV HRTEAIERAR LHIGKGVQLE CKGEGDVWVR CLSDHAVFVQ SYYLDREAGR
APGDAVHKIY PSAYIKVFDL RQCHRQMQQQ AATAQAAAAA QAAAVAGNIP GPGSVGGIAP
AISLSAAAGI GVDDLRRLCI LRMSFVKGWG PDYPRQSIKE TPCWIEIHLH RALQLLDEVL
HTMPIADPQP LD


Related products :

Catalog number Product name Quantity
EIAAB38719 Deletion target in pancreatic carcinoma 4 homolog,Dpc4,MAD homolog 4,Madh4,Mothers against decapentaplegic homolog 4,Mothers against DPP homolog 4,Mouse,Mus musculus,SMAD 4,SMAD family member 4,Smad4,
EIAAB38716 Deletion target in pancreatic carcinoma 4,DPC4,Homo sapiens,hSMAD4,Human,MAD homolog 4,MADH4,Mothers against decapentaplegic homolog 4,Mothers against DPP homolog 4,SMAD 4,SMAD family member 4,Smad4,S
EIAAB38715 MAD homolog 4,Madh4,Mothers against decapentaplegic homolog 4,Mothers against DPP homolog 4,Rat,Rattus norvegicus,SMAD 4,SMAD family member 4,Smad4,Smad4
EIAAB38717 Bos taurus,Bovine,MAD homolog 4,Mothers against decapentaplegic homolog 4,Mothers against DPP homolog 4,SMAD 4,SMAD family member 4,Smad4,SMAD4
EIAAB38718 MAD homolog 4,MADH4,Mothers against decapentaplegic homolog 4,Mothers against DPP homolog 4,Pig,SMAD 4,SMAD family member 4,Smad4,SMAD4,Sus scrofa
U0647h CLIA BSP1,BSP-1,Homo sapiens,hSMAD1,Human,JV4-1,MAD homolog 1,MADH1,MADR1,Mad-related protein 1,Mothers against decapentaplegic homolog 1,Mothers against DPP homolog 1,SMAD 1,SMAD family member 1,Smad 96T
E0647h ELISA BSP1,BSP-1,Homo sapiens,hSMAD1,Human,JV4-1,MAD homolog 1,MADH1,MADR1,Mad-related protein 1,Mothers against decapentaplegic homolog 1,Mothers against DPP homolog 1,SMAD 1,SMAD family member 1,Sma 96T
E0647h ELISA kit BSP1,BSP-1,Homo sapiens,hSMAD1,Human,JV4-1,MAD homolog 1,MADH1,MADR1,Mad-related protein 1,Mothers against decapentaplegic homolog 1,Mothers against DPP homolog 1,SMAD 1,SMAD family member 96T
E2184h ELISA kit hMAD-2,Homo sapiens,hSMAD2,Human,JV18-1,MAD homolog 2,MADH2,MADR2,Mad-related protein 2,Mothers against decapentaplegic homolog 2,Mothers against DPP homolog 2,SMAD 2,SMAD family member 2,S 96T
U2184h CLIA kit hMAD-2,Homo sapiens,hSMAD2,Human,JV18-1,MAD homolog 2,MADH2,MADR2,Mad-related protein 2,Mothers against decapentaplegic homolog 2,Mothers against DPP homolog 2,SMAD 2,SMAD family member 2,Sm 96T
E2184h ELISA hMAD-2,Homo sapiens,hSMAD2,Human,JV18-1,MAD homolog 2,MADH2,MADR2,Mad-related protein 2,Mothers against decapentaplegic homolog 2,Mothers against DPP homolog 2,SMAD 2,SMAD family member 2,Smad2, 96T
U2184h CLIA hMAD-2,Homo sapiens,hSMAD2,Human,JV18-1,MAD homolog 2,MADH2,MADR2,Mad-related protein 2,Mothers against decapentaplegic homolog 2,Mothers against DPP homolog 2,SMAD 2,SMAD family member 2,Smad2,S 96T
U2187m CLIA kit MAD homolog 6,Mad homolog 7,Madh6,Madh7,Mothers against decapentaplegic homolog 6,Mothers against DPP homolog 6,Mouse,Msmad6,Mus musculus,SMAD 6,SMAD family member 6,Smad6,Smad6 96T
E2187m ELISA MAD homolog 6,Mad homolog 7,Madh6,Madh7,Mothers against decapentaplegic homolog 6,Mothers against DPP homolog 6,Mouse,Msmad6,Mus musculus,SMAD 6,SMAD family member 6,Smad6,Smad6 96T
E2187m ELISA kit MAD homolog 6,Mad homolog 7,Madh6,Madh7,Mothers against decapentaplegic homolog 6,Mothers against DPP homolog 6,Mouse,Msmad6,Mus musculus,SMAD 6,SMAD family member 6,Smad6,Smad6 96T
U2187m CLIA MAD homolog 6,Mad homolog 7,Madh6,Madh7,Mothers against decapentaplegic homolog 6,Mothers against DPP homolog 6,Mouse,Msmad6,Mus musculus,SMAD 6,SMAD family member 6,Smad6,Smad6 96T
E2187m MAD homolog 6,Mad homolog 7,Madh6,Madh7,Mothers against decapentaplegic homolog 6,Mothers against DPP homolog 6,Mouse,Msmad6,Mus musculus,SMAD 6,SMAD family member 6,Smad6,Smad6
E2185h ELISA hMAD-3,Homo sapiens,hSMAD3,Human,JV15-2,MAD homolog 3,Mad3,MADH3,Mothers against decapentaplegic homolog 3,Mothers against DPP homolog 3,SMAD 3,SMAD family member 3,Smad3,SMAD3 96T
U2185h CLIA kit hMAD-3,Homo sapiens,hSMAD3,Human,JV15-2,MAD homolog 3,Mad3,MADH3,Mothers against decapentaplegic homolog 3,Mothers against DPP homolog 3,SMAD 3,SMAD family member 3,Smad3,SMAD3 96T
U2185h CLIA hMAD-3,Homo sapiens,hSMAD3,Human,JV15-2,MAD homolog 3,Mad3,MADH3,Mothers against decapentaplegic homolog 3,Mothers against DPP homolog 3,SMAD 3,SMAD family member 3,Smad3,SMAD3 96T
E2185h ELISA kit hMAD-3,Homo sapiens,hSMAD3,Human,JV15-2,MAD homolog 3,Mad3,MADH3,Mothers against decapentaplegic homolog 3,Mothers against DPP homolog 3,SMAD 3,SMAD family member 3,Smad3,SMAD3 96T
E2184m ELISA MAD homolog 2,Madh2,Madr2,Mad-related protein 2,mMad2,Mothers against decapentaplegic homolog 2,Mothers against DPP homolog 2,Mouse,Mus musculus,SMAD 2,SMAD family member 2,Smad2,Smad2 96T
E2185h hMAD-3,Homo sapiens,hSMAD3,Human,JV15-2,MAD homolog 3,Mad3,MADH3,Mothers against decapentaplegic homolog 3,Mothers against DPP homolog 3,SMAD 3,SMAD family member 3,Smad3,SMAD3
U2184m CLIA kit MAD homolog 2,Madh2,Madr2,Mad-related protein 2,mMad2,Mothers against decapentaplegic homolog 2,Mothers against DPP homolog 2,Mouse,Mus musculus,SMAD 2,SMAD family member 2,Smad2,Smad2 96T
E2184m ELISA kit MAD homolog 2,Madh2,Madr2,Mad-related protein 2,mMad2,Mothers against decapentaplegic homolog 2,Mothers against DPP homolog 2,Mouse,Mus musculus,SMAD 2,SMAD family member 2,Smad2,Smad2 96T
Pathways :
WP2341: vitamin B1 (thiamin) biosynthesis and salvage pathway
WP2340: Thiamine (vitamin B1) biosynthesis and salvage
WP32: Translation Factors
WP1596: Iron Homeostasis
WP1425: BMP signalling and regulation
WP539: Wnt Signaling Pathway NetPath
WP1045: TGF-beta Receptor Signaling Pathway
WP230: TGF Beta Signaling Pathway
WP934: Id Signaling Pathway
WP1058: Senescence and Autophagy
WP2377: Integrated Pancreatic Cancer Pathway
WP964: Cell cycle
WP1591: Heart Development
WP68: Androgen Receptor Signaling Pathway
WP179: Cell cycle
WP783: Androgen Receptor Signaling Pathway
WP1098: Wnt Signaling Pathway
WP265: Delta-Notch Signaling Pathway
WP1164: TGF Beta Signaling Pathway
WP341: Nodal signaling pathway
WP190: Cell cycle
WP815: Id Signaling Pathway
WP2039: CDKN1A-EGF-CREB
WP844: Cell cycle
WP1180: Delta-Notch Signaling Pathway

Related Genes :
[SMAD4 DPC4 MADH4] Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)
[Smad4 Dpc4 Madh4] Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)
[SMAD4 MADH4] Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)
[Smad4 Madh4] Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)
[SMAD1 BSP1 MADH1 MADR1] Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (JV4-1) (Mad-related protein 1) (SMAD family member 1) (SMAD 1) (Smad1) (hSMAD1) (Transforming growth factor-beta-signaling protein 1) (BSP-1)
[SMAD7 MADH7 MADH8] Mothers against decapentaplegic homolog 7 (MAD homolog 7) (Mothers against DPP homolog 7) (Mothers against decapentaplegic homolog 8) (MAD homolog 8) (Mothers against DPP homolog 8) (SMAD family member 7) (SMAD 7) (Smad7) (hSMAD7)
[Smad1 Madh1 Madr1] Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (Dwarfin-A) (Dwf-A) (Mothers-against-DPP-related 1) (Mad-related protein 1) (mMad1) (SMAD family member 1) (SMAD 1) (Smad1)
[Smad7 Madh7 Madh8] Mothers against decapentaplegic homolog 7 (MAD homolog 7) (Mothers against DPP homolog 7) (Mothers against decapentaplegic homolog 8) (MAD homolog 8) (Mothers against DPP homolog 8) (SMAD family member 7) (SMAD 7) (Smad7)
[SMAD3 MADH3] Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3)
[SMAD2 MADH2 MADR2] Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2)
[SMAD6 MADH6] Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6) (hSMAD6)
[Smad3 Madh3] Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3)
[Smad3 Madh3] Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (mMad3) (SMAD family member 3) (SMAD 3) (Smad3)
[Smad1 Mad1 Madh1] Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (SMAD family member 1) (SMAD 1) (Smad1)
[SMAD1] Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (SMAD family member 1) (SMAD 1) (Smad1)
[Smad7 Madh7] Mothers against decapentaplegic homolog 7 (MAD homolog 7) (Mothers against DPP homolog 7) (SMAD family member 7) (SMAD 7) (Smad7)
[SMAD4] Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)
[SMAD3 MADH3] Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3)
[Smox Dmel\CG2262 DSMAD2 DSmad2 dSMAD2 dSmad2 dsmad2 l(1)G0348 Sad sad Smad SMAD2 Smad2 smad2 SMOX SmoX smox ted tmp CG2262 Dmel_CG2262] Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member)
[Dcp1a Mitc1 Smif] mRNA-decapping enzyme 1A (EC 3.-.-.-) (MAD homolog 4-interacting transcription coactivator 1) (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF)
[ZFYVE9 MADHIP SARA SMADIP] Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)
[Mad CG12399] Protein mothers against dpp
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (Leader protein); Non-structural protein 2 (nsp2) (p65 homolog); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL2-PRO) (Papain-like proteinase) (PL-PRO); Non-structural protein 4 (nsp4); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (nsp5); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); Non-structural protein 11 (nsp11)]
[1a] Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (Leader protein); Non-structural protein 2 (nsp2) (p65 homolog); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL2-PRO) (Papain-like proteinase) (PL-PRO); Non-structural protein 4 (nsp4); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (nsp5); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); Non-structural protein 11 (nsp11)]
[Dana\GF20979 dana_GLEANR_4213 Dana_GF20979 GF20979] Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member)
[DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4] DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)
[repD ercc2 DDB_G0267414] General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (DNA excision repair cross-complementing protein-2 homolog) (DNA repair protein D) (TFIIH basal transcription factor complex helicase repD subunit)
[Dmoj\GI14415 Dmoj_GI14415] Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member)
[Dvir\GJ18762 Dvir_GJ18762 GJ18762] Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member)
[Dyak\GE17479 Dyak_GE17479] Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member)

Bibliography :